Ip A, Petrillo A, Della Pia A, Lee GG, et al. Phase 1b dose-finding study of rituximab, lenalidomide, and ibrutinib (R2I) in patients with relapsed/refractory mantle cell lymphoma. Leuk Lymphoma 2023 Sep 23:1-11. doi: 10.1080/10428194.2023.2259528.
PMID: 37740588